- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
- Video and telephone consultations
Dr Satyen Gohil specialises in treating patients with CLL, Lymphoma and histiocytic disorders. He has been involved and leads numerous clinical trials and is passionate about provided highly tailored treatment options for complex patients.
He also holds a particular interest in HLH (Haemophagocytic Lymphohistiocytosis) and am a core member of the UCLH national HLH MDT.
Areas of interest
Chronic Lymphocytic Leukaemia; CLL; Lymphoma; Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma; Mantle Cell Lymphoma; Follicular Lymphoma; Diffuse Large B Cell Lymphoma; Burkitt's Lymphoma; Marginal Zone Lymphoma; T Cell Lymphoma; Langerhans Cell Histiocytosis; Erdheim Chester Disease; Rosai Dorfman Disease; Histiocytic Disorders; Autografts; Autologous Bone Marrow Transplant; CAR-T Cell Therapy; Chimeric Antigen Receptor T Cell; Blood Cancer; Anaemia; Thrombocytopaenia; Lymphadenopathy; Lymph Nodes; Second Opinion
Current NHS consultant posts held
University College London Hospitals NHS Foundation Trust
(Additional) Languages spoken
- Gujarati - Fluent
A list of research publications can be found at:
- Doctor of Philosophy University College London 2018
- Bachelor of Medicine & Bachelor of Surgery King's College London 2006
Reference number 6143039
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Information for healthcare professionals (Bupa patients only, last 12 months)
Follow-up out-patient consultation - remote - (1-5)
Initial out-patient consultation - remote - (1-5)
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (1-5)